A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospital.
COVID-19
SARS-CoV-2
healthcare workers
risk factor analysis
sero-epidemiology
Journal
The Journal of infection
ISSN: 1532-2742
Titre abrégé: J Infect
Pays: England
ID NLM: 7908424
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
09
12
2020
revised:
24
08
2022
accepted:
25
08
2022
pubmed:
5
9
2022
medline:
19
10
2022
entrez:
4
9
2022
Statut:
ppublish
Résumé
To describe the risk factors for SARS-CoV-2 infection in UK healthcare workers (HCWs). We conducted a prospective sero-epidemiological study of HCWs at a major UK teaching hospital using a SARS-CoV-2 immunoassay. Risk factors for seropositivity were analysed using multivariate logistic regression. 410/5,698 (7·2%) staff tested positive for SARS-CoV-2 antibodies. Seroprevalence was higher in those working in designated COVID-19 areas compared with other areas (9·47% versus 6·16%) Healthcare assistants (aOR 2·06 [95%CI 1·14-3·71]; p=0·016) and domestic and portering staff (aOR 3·45 [95% CI 1·07-11·42]; p=0·039) had significantly higher seroprevalence than other staff groups after adjusting for age, sex, ethnicity and COVID-19 working location. Staff working in acute medicine and medical sub-specialities were also at higher risk (aOR 2·07 [95% CI 1·31-3·25]; p<0·002). Staff from Black, Asian and minority ethnic (BAME) backgrounds had an aOR of 1·65 (95% CI 1·32 - 2·07; p<0·001) compared to white staff; this increased risk was independent of COVID-19 area working. The only symptoms significantly associated with seropositivity in a multivariable model were loss of sense of taste or smell, fever, and myalgia; 31% of staff testing positive reported no prior symptoms. Risk of SARS-CoV-2 infection amongst HCWs is highly heterogeneous and influenced by COVID-19 working location, role, age and ethnicity. Increased risk amongst BAME staff cannot be accounted for solely by occupational factors.
Identifiants
pubmed: 36058413
pii: S0163-4453(22)00514-X
doi: 10.1016/j.jinf.2022.08.030
pmc: PMC9436870
mid: EMS154599
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
557-564Subventions
Organisme : Wellcome Trust
ID : 207498
Pays : United Kingdom
Informations de copyright
Copyright © 2022. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Competing interests The authors declare that they have no competing interests
Références
N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
Elife. 2020 Aug 21;9:
pubmed: 32820721
Anaesthesia. 2020 Aug;75(8):989-992
pubmed: 32397005
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
Lancet. 2021 May 8;397(10286):1725-1735
pubmed: 33901423
Int J Environ Res Public Health. 2022 Feb 17;19(4):
pubmed: 35206474
Lancet Reg Health Southeast Asia. 2022 Aug;3:100023
pubmed: 35769163
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33277297
Lancet Public Health. 2020 Sep;5(9):e475-e483
pubmed: 32745512
Nature. 2021 May;593(7858):266-269
pubmed: 33767447
BMJ Open. 2020 Aug 11;10(8):e039849
pubmed: 32784264
Thorax. 2020 Dec;75(12):1089-1094
pubmed: 32917840
Nat Med. 2020 Aug;26(8):1193-1195
pubmed: 32504052
Am J Epidemiol. 2021 Jan 4;190(1):161-175
pubmed: 32870978
Ann Intern Med. 2020 Sep 1;173(5):362-367
pubmed: 32491919
Lancet Infect Dis. 2020 Dec;20(12):1390-1400
pubmed: 32979318
Nat Commun. 2021 Feb 10;12(1):905
pubmed: 33568663
Elife. 2020 May 11;9:
pubmed: 32392129
BMJ Open Respir Res. 2020 Sep;7(1):
pubmed: 32873607
Infect Control Hosp Epidemiol. 2021 Apr;42(4):392-398
pubmed: 32962771
Lancet. 2020 Aug 29;396(10251):587-590
pubmed: 32758428
Lancet. 2021 Apr 17;397(10283):1459-1469
pubmed: 33844963
Clin Microbiol Infect. 2020 Dec;26(12):1690.e1-1690.e4
pubmed: 32898715
Lancet. 2020 Mar 21;395(10228):922
pubmed: 32199474
J Clin Virol. 2020 Jul;128:104437
pubmed: 32434708
J Hosp Infect. 2020 May;105(1):100-101
pubmed: 32147406
JAMA. 2020 Jul 14;324(2):195-197
pubmed: 32539107
Influenza Other Respir Viruses. 2020 Jul;14(4):474-475
pubmed: 32246886